The astroglial NF-κB was evaluated as a possible treatment target for the modulation of immune response in an experimental transgenic glaucoma mouse with deletion of IkappaB kinase beta (IκKβ) in astroglial cells (59). Here, NFKB1 is linked to glaucoma.